Mechanisms of Bone Impairment in Sickle Bone Disease
Abstract
:1. Introduction
2. Objective
3. Methods
3.1. Eligibility Criteria
3.2. Information Sources and Search Strategy
3.3. Study Selection
3.4. Data Collection Process and Data Items
4. Results
4.1. Biochemical Studies
4.2. Instrumental Studies
4.3. Biological Studies
5. Growth Pattern and Endocrine Complications
6. Discussion
7. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Piel, F.B.; Patil, A.P.; Howes, R.E.; Nyangiri, O.A.; Gething, P.W.; Dewi, M.; Temperley, W.H.; Williams, T.N.; Weatherall, D.J.; Hay, S.I. Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates. Lancet 2013, 381, 142–151. [Google Scholar] [CrossRef] [Green Version]
- GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385, 117–171. [Google Scholar] [CrossRef]
- Piel, F.B.; Patil, A.P.; Howes, R.E.; Nyangiri, O.A.; Gething, P.W.; Williams, T.N.; Weatherall, D.J.; Hay, S.I. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat. Commun. 2010, 1, 104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ballas, S.K.; Gupta, K.; Adams-Graves, P. Sickle cell pain: A critical reappraisal. Blood 2012, 120, 3647–3656. [Google Scholar] [CrossRef] [Green Version]
- Neonato, M.G.; Guilloud-Bataille, M.; Beauvais, P.; Begue, P.; Belloy, M.; Benkerrou, M.; Ducrocq, R.; Maier-Redelsperger, M.; de Montalembert, M.; Quinet, B.; et al. Acute clinical events in 299 homozygous sickle cell patients living in France. Eur. J. Haematol. 2000, 65, 155–164. [Google Scholar] [CrossRef]
- Ganesh, A.; William, R.R.; Mitra, S.; Yanamadala, S.; Hussein, S.S.; Alkindi, S.; Zakariah, M.; Al Lamki, Z.; Knox-Macaulay, H. Orbital involvement in sickle cell disease: A report of five cases and review literature. Eye 2001, 15, 774–780. [Google Scholar] [CrossRef] [Green Version]
- Demirbas, K.A.; Aktener, B.O.; Unsal, C. Pulpal necrosis with sickle cell anaemia. Int. Endodont J. 2004, 37, 602–606. [Google Scholar] [CrossRef]
- Stein, P.D.; Yaekoub, A.Y.; Matta, F.; Kleerekoper, M. Fat embolism syndrome. Am. J. Med. Sci. 2008, 336, 472–477. [Google Scholar] [CrossRef]
- Tsitsikas, D.A.; Vize, J.; Abukar, J. Fat Embolism Syndrome in Sickle Cell Disease. J. Clin. Med. 2020, 9, 3601. [Google Scholar] [CrossRef] [PubMed]
- Miller, R.G.; Segal, J.B.; Ashar, B.H.; Leung, S.; Ahmed, S.; Siddique, S.; Rice, T.; Lanzkron, S. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am. J. Hematol. 2006, 81, 236–241. [Google Scholar] [CrossRef] [PubMed]
- Garadah, T.S.; Hassan, A.B.; Jaradat, A.A.; Diab, D.E.; Kalafalla, H.O.; Kalifa, A.K.; Sequeira, R.P.; Alawadi, A.H. Predictors of abnormal bone mass density in adult patients with homozygous sickle-cell disease. Clin. Med. Insights Endocrinol. Diabetes 2015, 8, 35–40. [Google Scholar] [CrossRef] [Green Version]
- Osunkwo, I. An update on the recent literature on sickle cell bone disease. Curr. Opin. Endocrinol. Diabetes Obes. 2013, 20, 539–546. [Google Scholar] [CrossRef] [PubMed]
- Bordbar, M.R.; Haghpanah, S.; Zarei, T.; Dabbaghmanesh, M.H.; Omrani, G.R.; Saki, F. Evaluation of bone mineral density in children with sickle-cell anemia and its associated factors in the south of Iran: A case-control study. Arch. Osteoporos. 2017, 12, 70. [Google Scholar] [CrossRef]
- Hiram-Bab, S.; Liron, T.; Deshet-Unger, N.; Mittelman, M.; Gassmann, M.; Rauner, M.; Franke, K.; Wielockx, B.; Neumann, D.; Gabet, Y. Erythropoietin directly stimulates osteoclast precursors and induces bone loss. FASEB J. 2015, 29, 1890–1900. [Google Scholar] [CrossRef] [Green Version]
- Choudhry, H.; Harris, A.L. Advances in Hypoxia-Inducible Factor Biology. Cell Metab. 2018, 27, 281–298. [Google Scholar] [CrossRef]
- Santoro, N.; Colombini, A.; Silvestri, D.; Grassi, M.; Giordano, P.; Parasole, R.; Barisone, E.; Caruso, R.; Conter, V.; Valsecchi, M.G.; et al. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: An AIEOP experience. J. Pediatr. Hematol. Oncol. 2013, 35, 348–355. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Toxqui, L.; Vaquero, M.P. Chronic iron deficiency as an emerging risk factor for osteoporosis: A hypothesis. Nutrients 2015, 7, 2324–2344. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Giustina, A.; Bouillon, R.; Binkley, N.; Sempos, C.; Adler, R.A.; Bollerslev, J.; Dawson-Hughes, B.; Ebeling, P.R.; Feldman, D.; Heijboer, A.; et al. Controversies in Vitamin D: A Statement from the Third International Conference. JBMR Plus 2020, 4, e10417. [Google Scholar] [CrossRef]
- Nolan, V.G.; Nottage, K.A.; Cole, E.W.; Hankins, J.S.; Gurney, J.G. Prevalence of vitamin D deficiency in sickle cell disease: A systematic review. PLoS ONE 2015, 10, e0119908. [Google Scholar] [CrossRef]
- Buison, A.M.; Kawchak, D.A.; Schall, J.; Ohene-Frempong, K.; Stallings, V.A.; Zemel, B.S. Low vitamin D status in children with sickle cell disease. J. Pediatr. 2004, 145, 622–627. [Google Scholar] [CrossRef] [PubMed]
- Sadat-Ali, M.; Al-Elq, A.; Al-Turki, H.; Sultan, O.; Al-Ali, A.; Al Mulhim, F. Vitamin D level among patients with sickle cell anemia and its influence on bone mass. Am. J. Hematol. 2011, 86, 506–507. [Google Scholar] [CrossRef]
- Barden, E.M.; Zemel, B.S.; Kawchak, D.A.; Goran, M.I.; Ohene-Frempong, K.; Stallings, V.A. Total and resting energy expenditure in children with sickle cell disease. J. Pediatr. 2000, 136, 73–79. [Google Scholar] [CrossRef]
- Arlet, J.B.; Courbebaisse, M.; Chatellier, G.; Eladari, D.; Souberbielle, J.C.; Friedlander, G.; de Montalembert, M.; Prié, D.; Pouchot, J.; Ribeil, J.A. Relationship between vitamin D deficiency and bone fragility in sickle cell disease: A cohort study of 56 adults. Bone 2013, 52, 206–211. [Google Scholar] [CrossRef]
- Voskaridou, E.; Stoupa, E.; Antoniadou, L.; Premetis, E.; Konstantopoulos, K.; Papassotiriou, I.; Terpos, E. Osteoporosis and osteosclerosis in sickle cell/β-thalassemia: The role of the RANKL/osteoprotegerin axis. Haematologica 2006, 91, 813–816. [Google Scholar] [PubMed]
- Sadat-Ali, M.; Al-Elq, A.; Sultan, O.; Al-Turki, H. Secondary osteoporosis due to sickle cell anemia: Do sex steroids play a role? Indian J. Med. Sci. 2008, 62, 193–198. [Google Scholar] [CrossRef] [Green Version]
- Faienza, M.F.; Giordani, L.; Delvecchio, M.; Cavallo, L. Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency. J. Endocrinol. Investig. 2008, 31, 85–91. [Google Scholar] [CrossRef]
- De Luna, G.; Ranque, B.; Courbebaisse, M.; Ribeil, J.A.; Khimoud, D.; Dupeux, S.; Silvera, J.; Oredo, L.; Pouchot, J.; Arlet, J.B. High bone mineral density in sickle cell disease: Prevalence and characteristics. Bone 2018, 110, 199–203. [Google Scholar] [CrossRef] [PubMed]
- Barden, E.M.; Kawchak, D.A.; Ohene-Frempong, K.; Stallings, V.A.; Zemel, B.S. Body composition in children with sickle cell disease. Am. J. Clin. Nutr. 2002, 76, 218–225. [Google Scholar] [CrossRef] [Green Version]
- Kennedy, T.S.; Fung, E.B.; Kawchak, D.A.; Zemel, B.S.; Ohene-Frempong, K.; Stallings, V.A. Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J. Pediatr. Hematol./Oncol. 2001, 23, 165–169. [Google Scholar] [CrossRef] [PubMed]
- Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.; Clarke, M.; Devereaux, P.J.; Kleijnen, J.; Moher, D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J. Clin. Epidemiol. 2009, 62, e1–e34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fung, E.B.; Kawchak, D.A.; Zemel, B.S.; Rovner, A.J.; Ohene-Frempong, K.; Stallings, V.A. Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia. Pediatr. Blood Cancer 2008, 50, 620–623. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mokhtar, G.M.; Tantawy, A.A.; Hamed, A.A.; Adly, A.A.; Ismail, E.A.; Makkeyah, S.M. Tartrate-resistant acid phosphatase 5b in young patients with sickle cell disease and trait siblings: Relation to vasculopathy and bone mineral density. Clin. Appl. Thromb. Hemost. 2017, 23, 64–71. [Google Scholar] [CrossRef] [Green Version]
- Nouraie, M.; Cheng, K.; Niu, X.; Moore-King, E.; Fadojutimi-Akinsi, M.F.; Minniti, C.P.; Sable, C.; Rana, S.; Dham, N.; Campbell, A.; et al. Predictors of osteoclast activity in patients with sickle cell disease. Haematologica 2011, 96, 1092–1098. [Google Scholar] [CrossRef] [PubMed]
- Faienza, M.F.; Brunetti, G.; Ventura, A.; Piacente, L.; Messina, M.F.; De Luca, F.; Ciccarelli, M.; Oranger, A.; Mori, G.; Natale, M.P.; et al. Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner Syndrome. Bone 2015, 81, 228–236. [Google Scholar] [CrossRef] [PubMed]
- Mohammed, S.M.; Suleiman, S.A.; Addae, S.K.; Annobil, S.H.; Adzaku, F.K.; Kadoummi, O.F.; Richards, J.T. Urinary hydroxyproline and serum alkaline phosphatase in sickle cell disease. Clin. Chim. Acta 1991, 203, 285–294. [Google Scholar] [CrossRef]
- Bolarin, D.M.; Azinge, E.C. Osteocalcin and specific markers of bone resorption in sickle cell disease. Acta Physiol. Hung. 2010, 97, 290–296. [Google Scholar] [CrossRef]
- Osunkwo, I.; Hodgman, E.I.; Cherry, K.; Dampier, C.; Eckman, J.; Ziegler, T.R.; Ofori-Acquah, S.; Tangpricha, V. Vitamin D deficiency and chronic pain in Sickle Cell Disease. Br. J. Haematol. 2011, 153, 538–540. [Google Scholar] [CrossRef]
- Lee, M.T.; Licursi, M.; Mcmahon, D.J. Vitamin D deficiency and acute vaso-occlusive complications in children with sickle cell disease. Pediatr. Blood Cancer 2015, 62, 643–647. [Google Scholar] [CrossRef]
- Han, J.; Zhang, X.; Saraf, S.L.; Gowhari, M.; Molokie, R.E.; Hassan, J.; Jain, S.; Shah, B.N.; Abbasi, T.; Machado, R.F.; et al. Risk factors for vitamin D deficiency in sickle cell disease. Br. J. Haematol. 2018, 181, 828–835. [Google Scholar] [CrossRef] [PubMed]
- Zafra, F.; Ibáñez, I.; Giménez, C. Glycinergic transmission: Glycine transporter GlyT2 in neuronal pathologies. Neuronal Signal. 2016, 1, NS20160009. [Google Scholar] [CrossRef] [Green Version]
- Grégoire-Pelchat, P.; Pastore, Y.; Robitaille, N.; LeMay, S.; Khamessan, A.; Kleiber, N.; Nyalendo, C.; Gagné, N.; Alos, N.; Mailhot, G. Comparison of two vitamin D supplementation strategies in children with sickle cell disease: A randomized controlled trial. Br. J. Haematol. 2020. [Google Scholar] [CrossRef]
- Aceto, G.; D’Addato, O.; Messina, G.; Carbone, V.; Cavallo, L.; Brunetti, G.; Faienza, M.F. Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS. Pediatr. Nephrol. 2014, 29, 2147–2155. [Google Scholar] [CrossRef]
- Kanis, J.A.; On behalf of the World Health Organization Scientific Group. Assessment of Osteoporosis at the Primary Health-Care Level; Technical Report; World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield: Sheffield, UK, 2007. [Google Scholar]
- Genant, H.K.; Wu, C.Y.; van Kuijk, C.; Nevitt, M.C. Vertebral fracture assessment using a semiquantitative technique. J. Bone Miner. Res. 1993, 8, 1137–1148. [Google Scholar] [CrossRef] [PubMed]
- De Franceschi, L.; Gabbiani, D.; Giusti, A.; Forni, G.; Stefanoni, F.; Pinto, V.M.; Sartori, G.; Balocco, M.; Dal Zotto, C.; Valenti, M.T.; et al. Development of algorithm for clinical management of sickle cell bone disease: Evidence for a role of vertebral fractures in patient follow-up. J. Clin. Med. 2020, 9, 1601. [Google Scholar] [CrossRef]
- Chapelon, E.; Garabedian, M.; Brousse, V.; Souberbielle, J.C.; Bresson, J.L.; de Montalembert, M. Osteopenia and vitamin D deficiency in children with sickle cell disease. Eur. J. Haematol. 2009, 83, 572–578. [Google Scholar] [CrossRef]
- Buison, A.M.; Kawchak, D.A.; Schall, J.I.; Ohene-Frempong, K.; Stallings, V.A.; Leonard, M.B.; Zemel, B.S. Bone area and bone mineral content deficits in children with sickle cell disease. Pediatrics 2005, 116, 943–949. [Google Scholar] [CrossRef]
- Raggatt, L.J.; Partridge, N.C. Cellular and Molecular Mechanisms of Bone Remodeling. J. Biol. Chem. 2010, 285, 25103–25108. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Faienza, M.F.; Ventura, A.; Marzano, F.; Cavallo, L. Postmenopausal osteoporosis: The role of immune system cells. Clin. Dev. Immunol. 2013, 2013, 575936. [Google Scholar] [CrossRef] [Green Version]
- Valderrábano, R.J.; Wu, J.Y. Bone and blood interactions in human health and disease. Bone 2019, 119, 65–70. [Google Scholar] [CrossRef]
- Brunetti, G.; D’Amato, G.; Chiarito, M.; Tullo, A.; Colaianni, G.; Colucci, S.; Grano, M.; Faienza, M.F. An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases. World J. Pediatr. 2019, 15, 4–11. [Google Scholar] [CrossRef] [PubMed]
- Tombak, A.; Boztepe, B.; Akbayir, S.; Dogru, G.; Sungur, M.A. Receptor Activator of Nuclear Factor κ-Β Ligand/Osteoprotegerin Axis in Adults with Hb S/β-Thalassemia and β-Thalassemia Trait. Hemoglobin 2020, 44, 334–337. [Google Scholar] [CrossRef]
- Carbonare, L.D.; Matte’, A.; Valenti, M.T.; Siciliano, A.; Mori, A.; Schweiger, V.; Zampieri, G.; Perbellini, L.; De Franceschi, L. Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease. Blood 2015, 126, 2320–2328. [Google Scholar] [CrossRef] [Green Version]
- Rana, K.; Pantoja, K.; Xiao, L. Bone marrow neutrophil aging in sickle cell disease mice is associated with impaired osteoblast functions. Biochem. Biophys. Rep. 2018, 16, 110–114. [Google Scholar] [CrossRef]
- Mandese, V.; Bigi, E.; Bruzzi, P.; Palazzi, G.; Predieri, B.; Lucaccioni, L.; Cellini, M.; Iughetti, L. Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study. BMC Pediatr. 2019, 19, 56. [Google Scholar] [CrossRef] [PubMed]
- Ozen, S.; Unal, S.; Erçetin, N.; Taşdelen, B. Frequency and risk factors of endocrine complications in Turkish children and adolescents with sickle cell anemia. Turk. J. Haematol. 2013, 30, 25–31. [Google Scholar] [CrossRef]
- Soliman, T.; De Sanctis, T.; Yassin, M.; Adel, A. Growth and growth hormone-Insulin Like Growth Factor—I (GH-IGF-I) axis in chronic anemias. Acta Biomed. 2017, 88, 101–111. [Google Scholar] [PubMed]
- Luporini, S.M.; Bendit, I.; Manhani, R.; Bracco, O.L.; Manzella, L.; Giannella-Neto, D. Growth hormone and insulin-like growth factor I axis and growth of children with different sickle cell anemia haplotypes. J. Pediatr. Endocrinol. Metab. 2007, 20, 211–218. [Google Scholar] [CrossRef]
- Garrido, C.; Cela, E.; Belendez, C.; Mata, C.; Huerta, J. Status of vitamin D in children with sickle cell disease living in Madrid, Spain. Eur. J. Pediatr. 2012, 171, 1793–1798. [Google Scholar] [CrossRef] [PubMed]
- O’Connor, M.Y.; Thoreson, C.K.; Ramsey, N.L.; Ricks, M.; Sumner, A.E. The uncertain significance of low vitamin D levels in African descent populations: A review of the bone and cardiometabolic literature. Prog. Cardiovasc. Dis. 2013, 56, 261–269. [Google Scholar] [CrossRef] [Green Version]
- Waldron, J.L.; Ashby, H.L.; Cornes, M.P.; Bechervaise, J.; Razavi, C.; Thomas, O.L.; Chugh, S.; Deshpande, S.; Ford, C.; Gama, R. Vitamin D: A negative acute phase reactant. J. Clin. Pathol. 2013, 66, 620–622. [Google Scholar] [CrossRef]
- Ginde, A.A.; Liu, M.C.; Camargo, C.A., Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch. Intern. Med. 2009, 169, 626–632. [Google Scholar] [CrossRef] [Green Version]
- Gutierrez, O.M.; Farwell, W.R.; Kermah, D.; Taylor, E.N. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos. Int. 2011, 22, 1745–1753. [Google Scholar] [CrossRef] [Green Version]
- Goodman, B.M.; Artz, N.; Radford, B.; Chen, I.A. Prevalence of vitamin D deficiency in adults with sickle cell disease. J. Natl. Med. Assoc. 2010, 102, 332–335. [Google Scholar] [CrossRef]
- Faienza, M.F.; Ventura, A.; Colucci, S.; Cavallo, L.; Grano, M.; Brunetti, G. Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies. Front. Endocrinol. 2016, 7, 34. [Google Scholar] [CrossRef] [Green Version]
- Bertelloni, S.; Balsamo, A.; Giordani, L.; Fischetto, R.; Russo, G.; Delvecchio, M.; Gennari, M.; Nicoletti, A.; Maggio, M.C.; Concolino, D.; et al. 17beta-Hydroxysteroid dehydrogenase-3 deficiency: From pregnancy to adolescence. J. Endocrinol. Investig. 2009, 32, 666–670. [Google Scholar] [CrossRef]
- Faienza, M.F.; Acquafredda, A.; Tesse, R.; Luce, V.; Ventura, A.; Maggialetti, N.; Monteduro, M.; Giordano, P.; Cavallo, L. Risk factors for subclinical atherosclerosis in diabetic and obese children. Int. J. Med. Sci. 2013, 10, 338–343. [Google Scholar] [CrossRef] [Green Version]
- Smiley, D.; Dagogo-Jack, S.; Umpierrez, G. Therapy insight: Metabolic and endocrine disorders in sickle cell disease. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4, 102–109. [Google Scholar] [CrossRef] [PubMed]
- Miniello, V.L.; Faienza, M.F.; Scicchitano, P.; Cortese, F.; Gesualdo, M.; Zito, A.; Basile, M.; Recchia, P.; Leogrande, D.; Viola, D.; et al. Insulin resistance and endothelial function in children and adolescents. Int. J. Cardiol. 2014, 174, 343–347. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Giordano, P.; Urbano, F.; Lassandro, G.; Faienza, M.F. Mechanisms of Bone Impairment in Sickle Bone Disease. Int. J. Environ. Res. Public Health 2021, 18, 1832. https://doi.org/10.3390/ijerph18041832
Giordano P, Urbano F, Lassandro G, Faienza MF. Mechanisms of Bone Impairment in Sickle Bone Disease. International Journal of Environmental Research and Public Health. 2021; 18(4):1832. https://doi.org/10.3390/ijerph18041832
Chicago/Turabian StyleGiordano, Paola, Flavia Urbano, Giuseppe Lassandro, and Maria Felicia Faienza. 2021. "Mechanisms of Bone Impairment in Sickle Bone Disease" International Journal of Environmental Research and Public Health 18, no. 4: 1832. https://doi.org/10.3390/ijerph18041832